Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Sanara MedTech (SMTI) PT Lowered to $44 at Cantor Fitzgerald
-
Sanara MedTech to Participate in Two Upcoming Conferences
-
Sanara MedTech Inc. Announces First Quarter 2023 Results
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Results
-
Sanara MedTech (SMTI) PT Raised to $50 at Cantor Fitzgerald Post Accretive Scendia Acquisition, Encourage Investors to Acquire Undervalued Shares
-
Sanara MedTech (SMTI) PT Lowered to $40 at Cantor Fitzgerald, Overweight Rating Maintained
-
UPDATE: Cantor Fitzgerald Starts Sanara MedTech (SMTI) at Overweight
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2020 Results
-
Sanara MedTech Inc. Announces Closing of $31.6 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Sanara MedTech (SMTI) Prices 1.1M Share Common Stock Offering at $25/Each
-
Sanara MedTech Inc. Announces Pricing of Public Offering
-
Sanara MedTech (SMTI) to Offer Common Stock
-
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
